Rune Johansson

Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

A. Risedal, F. Piehl, E. Gilland, 2022, The Lancet Neurology.

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

Timothy A. Miller, Stephen A. Goutman, N. Staff, 2021, The Lancet Neurology.

Pharmacokinetics of Levetiracetam during Pregnancy, Delivery, in the Neonatal Period, and Lactation

E. Ben-Menachem, T. Tomson, R. Palm, 2007, Epilepsia.

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

F. Piehl, A. Punga, A. Budzianowska, 2022, JAMA neurology.

Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort

F. Piehl, A. Budzianowska, P. Sundström, 2021, Neurology.

Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort

F. Piehl, A. Budzianowska, P. Sundström, 2021, Neurology.